Akinda screens Monopar Therapeutics Inc. (MNPR) using Islamic finance criteria. The current classification is Not Halal. Screening is informational and not a fatwa; consult a qualified scholar for personal guidance.

Whether a Muslim may invest depends on your school of thought and the stock's Shariah classification. On Akinda, Monopar Therapeutics Inc. (MNPR) is currently labeled Not Halal. Always verify with your own research and advisors.

You can view Monopar Therapeutics Inc.'s Shariah status on this symbol page (ticker MNPR), in the header, and on the Summary tab. The Akinda app shows the same screening when you search for MNPR.

Monopar Therapeutics Inc. (MNPR) receives its label from Akinda's methodology: business activity (non-permissible revenue) and financial ratios (interest-bearing debt and assets) are compared to published thresholds. The result Not Halal reflects those screens at the time of the latest data.

Yes. Monopar Therapeutics Inc. (MNPR) can move from Halal to Doubtful or Not halal if revenue mix, debt, or impermissible income crosses Akinda's limits. Check MNPR periodically—Akinda updates results when new filings arrive.